Table 1 Cyclins D2 and D3 expression in de novo CD5 + and CD5 − DLBCLs
From: De novo CD5-positive diffuse large B-cell lymphomas show high specificity for cyclin D2 expression
|  | De novo CD5+DLBCLs | CD5−DLBCLs | P |
|---|---|---|---|
Cyclin D2 | 50/51 (98%) | 14/51 (28%) | P < 0.0001 |
Cyclin D3 | 18/51 (35%) | 24/51 (47%) | P = 0.23 |